The expanding role of imaging in the management of renal cell carcinoma

References

• Prasad PR, Humphrey PA, Catena JR et al. Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. Radiographics26(6), 1795–1810 (2006).
   PubMed Web of Science ®Google Scholar
• Israel GM, Bosniak MA. Renal imaging for diagnosis and staging of renal cell carcinoma. Urol. Clin. N. Am.30(3), 499–514 (2003).
   PubMed Web of Science ®Google Scholar
• Cohen HT, McGovern FJ. Renal cell carcinoma. N. Engl. J. Med.353(23), 2477–2490 (2005).
   PubMed Web of Science ®Google Scholar
• Lopez-Beltran A, Carrasco JC, Cheng L et al. 2009 update on the classification of renal epithelial tumors in adults. Intl J. Urol.16(5), 432–443 (2009).
   PubMed Web of Science ®Google Scholar
• Meyer PN, Clark JI, Flanigan RC et al. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults. Am. J. Clin. Pathol.128(1), 70–79 (2007).
   PubMed Web of Science ®Google Scholar
• Ho VB, Scott AF, Hood MH et al. Renal masses: quantitative assessment of enhancement with dynamic MR imaging. Radiology224(3), 695–700 (2002).
   PubMed Web of Science ®Google Scholar
• Pedrosa I, Alsop DC, Rofski NM. Magnetic resonance imaging as a biomarker in renal cell carcinoma. Cancer115(10), 2334–2345 (2009).
   PubMed Web of Science ®Google Scholar
• Yoshimitsu K, Irie H, Tajima T et al. MR imaging of renal cell carcinoma: its role in determining cell type. Radiat. Med.22(6), 371–376 (2004).
   PubMedGoogle Scholar
• Pedrosa I, Chou MT, Ngo L et al. MR classification of renal masses with pathological correlation. Eur. Radiol.18(2), 365–375 (2008).
   PubMed Web of Science ®Google Scholar
• Rioja J, Macarena RF, Ricardo LF et al. Role of positron emission tomography in urological oncology. BJU Int.106, 1578–1594 (2010).
   PubMed Web of Science ®Google Scholar
• Shvarts O, Han K, Seltzer M et al. Positron emission tomography in urologic oncology. Cancer Control9(4), 335–342 (2002).
   PubMedGoogle Scholar
• Cheville JC, Lohse CM, Zincke H et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am. J. Surg. Pathol.27(5), 612–624 (2003).
   PubMed Web of Science ®Google Scholar
• Vikram R, Ng CS, Tamboli P et al. Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease. Radiographics29(3), 741–757 (2009).
   PubMed Web of Science ®Google Scholar
• Oliva MR, Glickman J, Zou KH et al. Renal cell carcinoma: T1 and T2 signal characteristics of papillary and clear-cell types correlated with pathology. AJR Am. J. Roentgenol.192(6), 1524–1530 (2009).
   PubMed Web of Science ®Google Scholar
• Schrader AJ, Olbert PJ, Hegele A et al. Metastatic non-clear-cell renal cell carcinoma: current therapeutic options. BJU Int.101(1), 1343–1345 (2008).
   PubMed Web of Science ®Google Scholar
• Kim JI, Cho JY, Moon KC et al. Segmental Enhancement inversion at biphasic CT: characteristic finding of small renal oncocytomas. Radiology252(2), 441–448 (2009).
   PubMed Web of Science ®Google Scholar
• Siegel CL, McFarland EG, Brink JA et al. CT of cystic renal masses: analysis of diagnostic performance and interobserver variation. Am. J. Roentgenol.169(3), 813–818 (1997).
   PubMed Web of Science ®Google Scholar
• Bosniak MA. The current radiological approach to renal cysts. Radiology158(1), 1–10 (1986).
   PubMed Web of Science ®Google Scholar
• Bosniak MA. Problems in the radiologic diagnosis of renal parenchymal tumors. Urol. Clin. North Am.20(2), 217–230 (1993).
   PubMed Web of Science ®Google Scholar
• Bosniak MA. Diagnosis and management of patients with complicated cystic lesions of the kidney. Am. J. Roentgenol.169(3), 819–821 (1997).
   PubMed Web of Science ®Google Scholar
• Warren KS, McFarlane W. The Bosniak Classification of renal cystic masses. BJU Int.95(7), 939–942 (2005).
   PubMed Web of Science ®Google Scholar
• Bosniak MA. The small (less than or equal to 3.0 cm) renal parenchymal tumor: detection, diagnosis, and controversies. Radiology179(2), 307–317 (1991).
   PubMed Web of Science ®Google Scholar
• Corica FA, Iczkowski KA, Cheng L et al. Cystic renal cell carcinoma is cured by resection: a study of 24 cases with long-term followup. J. Urol.161(2), 408 (1999).
   PubMed Web of Science ®Google Scholar
• Nassir A, Jollimore J, Gupta R et al. Multilocular cystic renal cell carcinoma: a series of 12 cases and review of the literature. Urology60(3), 421–427 (2002).
   PubMed Web of Science ®Google Scholar
• Aubert S, Zini L, Delomez J et al. Cystic renal cell carcinomas in adults. Is preoperative recognition of multilocular cystic renal cell carcinoma possible? J. Urol.174(6), 2115–2119 (2005).
   PubMed Web of Science ®Google Scholar
• Tosaka A, Yoshida K, Kobayashi N et al. [A report of two cases of multilocular cystic renal cell carcinoma: review of 51 cases reported and the results of a prognostic survey.] Hinyokika Kiyo38(9), 1045–1050 (1992).
   PubMedGoogle Scholar
• Suzigan S, Lopez-Beltran A, Montironi R et al. Multilocular cystic renal cell carcinoma; a report of 45 cases of a kidney tumor of low malignant potential. Am. J. Clin. Pathol.125(2), 217–222 (2006).
   PubMed Web of Science ®Google Scholar
• Freire M, Remer EM. Clinical and radiological features of cystic renal masses. AJR Am. J. Roentgenol.192(5), 1367–1372 (2009).
   PubMed Web of Science ®Google Scholar
• Turkvatan A, Akdur O, Altinel M et al. Preoperative staging of renal cell carcinoma with multidetector CT. Diagn. Interv. Radiol.15(1), 22–30 (2009).
   PubMed Web of Science ®Google Scholar
• Culine S, Bekradda M, Kramar A et al. Prognostic factors for survival in patients with brain metastases from renal cell carcinoma. Cancer83(12), 2548–2553 (1998).
   PubMed Web of Science ®Google Scholar
• Edge SB, Byrd DR, Compton CC et al. (Eds). AJCC Cancer Staging Manual (7th Edition). Springer, New York, NY, USA (2010).
   Google Scholar
• Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J. Urol.166(1), 6–18 (2001).
   PubMed Web of Science ®Google Scholar
• Gervais DA, McGovern FJ, Arellano et al. Radiofrequency ablation of renal cell carcinoma: part 1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am. J. Roentgenol.185(1), 64–71 (2005).
   PubMed Web of Science ®Google Scholar
• Hui GC, Tuncali K, Tatli et al. Comparison of percutaneous and surgical approaches to renal tumor ablation: metaanalysis of effectiveness and complication rates. J. Vasc. Interv. Radiol.19(9), 1311–1320 (2008).
   PubMed Web of Science ®Google Scholar
• Park S, Cadeddu JA. Outcomes of radiofrequency ablation for kidney cancer. Cancer Control14(3), 205–210 (2007).
   PubMedGoogle Scholar
• Schirmang TC, Mayo-Smith WW, Dupuy DE et al. kidney neoplasms: renal halo sign after percutaneous radiofrequency ablation – incidence and clinical importance in 101 consecutive patients. Radiology253(1), 263–269 (2009).
   PubMed Web of Science ®Google Scholar
• Leveridge MJ, Mattar K, Kachura J et al. Assessing outcomes in probe ablative therapies for small renal masses. J. Endourol.24(5), 759–764 (2010).
   PubMed Web of Science ®Google Scholar
• Escudier B, Eisen T, Stadler WM et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N. Engl. J. Med.356(2), 125–134 (2007).
   PubMed Web of Science ®Google Scholar
• Fisher RI, Rosenberg SA, Fyfe G. Longterm survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma. Cancer J. Sci. Am.6(1), S55–S57 (2000).
   PubMed Web of Science ®Google Scholar
• Motzer RJ, Hutson TE, Tomczak P et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N. Engl. J. Med.356(2), 115–124 (2007).
   PubMed Web of Science ®Google Scholar
• Zee YK, O’Connor JPB Parker GJM et al. Imaging angiogenesis of genitourinary tumors. Nat. Rev. Radiol.7(2), 69–82 (2010).
   Web of Science ®Google Scholar
• Fournier LS, Oudard S, Thiam R et al. Metastatic renal cell carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT. Radiology256(2), 511–518 (2010).
   PubMed Web of Science ®Google Scholar
• Smith AD, Shah SN, Rini BI et al. Morphology, attenuation, size, and structure (mass) criteria: assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy. AJR Am. J. Roentgenol.194(6), 1470–1478 (2010).
   PubMed Web of Science ®Google Scholar
• Gill IS, Monish A, Gervais DA et al. Small renal masses. N. Engl. J. Med.362(7), 624–634 (2010).
   PubMed Web of Science ®Google Scholar
• Kane CJ, Mallin K, Ritchey J et al. Renal cell cancer stage migration. Analysis of the national cancer data base. Cancer113(1), 78–83 (2008).
   PubMed Web of Science ®Google Scholar
• Kunkle DA, Crispen PL, Chen DYT et al. Enhancing renal masses with zero net growth during active surveillance. J. Urol.177(3), 849–854 (2007).
   PubMed Web of Science ®Google Scholar
• Tuncali K, van Sonnenberg E, Shankar S et al. Evaluation of patients referred for percutaneous ablation of renal tumors: importance of a preprocedural diagnosis. AJR Am. J. Roentgenol.183(3), 575–582 (2004).
   PubMed Web of Science ®Google Scholar
• Gabr AH, Gdor Y, Roberts WW et al. Radiographic surveillance of minimally and moderately complex renal cysts. BJU Int.103(8), 1116–1119 (2008).
   PubMed Web of Science ®Google Scholar
• Kunkle DA, Egleston BL, Uzzo GR. Excise, ablate or observe: the small renal mass dilemma a meta-analysis and review. J. Urol.179(4), 1227–1234 (2008).
   PubMed Web of Science ®Google Scholar
• Silverman SG, Gan YU, Mortele KJ, Tuncali K, Cibas ES. Renal masses in the adult patient: the role of percutaneous biopsy. Radiology240(1), 6–22 (2006).
   PubMed Web of Science ®Google Scholar